PAKISTAN ARMED FORCES
MEDICAL JOURNAL (Category Y)

A Journal of Army Medical & Dental Corps

Being published since 1956

ISSN (online) 2411-8842
ISSN (print) 0030-9648

VOL 68, No. 2, APRIL 2018

ALISKERIN: A DIRECT RENIN INHIBITOR IMPROVES PANCREATIC FUNCTIONAL B CELL MASS IN TYPE 2 DIABETIC MICE

Asma Khan, Bushra Tayyaba Khan*, Salman Bakhtiar**, Aroosa Ishtiaq Butt

Abstract

Objective: To evaluate the effects of Aliskerin on functional pancreatic β cell mass in type 2 diabetic mice.
Study Design: Analytical experimental study.
Place and Duration of Study: The study was conducted at the animal house of National Institute of Health, Islamabad. Duration of the study was of twelve weeks after initial acclimatization of one week.
Material and Methods: Twenty four BALB/c mice, both male and female, of 35 to 40 grams were used for this study. Animals were randomly divided into four groups. Two served as control, one was normal and the other was diabetic control. The remaining two were used as interventional groups and received either pioglitazone or aliskerin for four weeks after induction of diabetes. Fasting blood glucose levels with fasting insulin levels were estimated. Insulin resistance was determined by calculating homa IR and pancreatic morphology was assessed by
evaluating pancreatic beta cell mass.
Results: After treatment, pioglitazone reduced all the biochemical parameters significantly when compared with diabetic control and negative correlation between glucose and insulin was changed into positive correlation (r value, 0.92) with significant p-value (0.015), while aliskerin caused a significant rise (p-value 0.009) in functional pancreatic β cell mass.
Conclusion: Aliskerin has a significant anti-diabetic role as far as pancreatic morphology is concerned.

Keywords : Diabetes mellitus, Homeostatic model assessment for insulin resistance, Peroxisome proliferator activated receptor gamma, Renin angiotensin system.



Creative Commons License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.